These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12918680)

  • 1. Association of HLA-B51 with clinical expression of Behçet's disease. Analysis of 201 Iranian patients.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():147-8. PubMed ID: 12918680
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
    Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
    Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B51 frequency in Iranian patients with Behçet's disease.
    Shahram F; Davatchi F; Nadji A; Jamshidi A; Bahar K; Akbarian M; Chams C
    Adv Exp Med Biol; 2003; 528():229-30. PubMed ID: 12918696
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylator phenotype in Behçet's disease.
    Najim RA; Sharquie KE; Al-Janabi MH
    Adv Exp Med Biol; 2003; 528():131-8. PubMed ID: 12918677
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
    Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
    Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MICA transmembrane region polymorphism and HLA B51 in Tunisian Behçet's disease patients.
    Ben Ahmed M; Houman H; Abdelhak S; Ben Ghorbel I; Miled M; Dellagi K; Louzir H
    Adv Exp Med Biol; 2003; 528():225-8. PubMed ID: 12918695
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of oral aphthae in Behçet's disease and idiopathic recurrent aphthous stomatitis.
    Chams-Davatchi C; Shizarpour M; Davatchi F; Shahram F; Chams H; Nadji A; Jamshidi AR
    Adv Exp Med Biol; 2003; 528():317-20. PubMed ID: 12918713
    [No Abstract]   [Full Text] [Related]  

  • 8. Behçet's disease in patients of German and Turkish origin--a comparative study.
    Kötter I; Vonthein R; Günaydin I; Müller C; Kanz L; Zierhut M; Stübiger N
    Adv Exp Med Biol; 2003; 528():53-8. PubMed ID: 12918660
    [No Abstract]   [Full Text] [Related]  

  • 9. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101.
    Mizuki N; Inoko H; Ando H; Nakamura S; Kashiwase K; Akaza T; Fujino Y; Masuda K; Takiguchi M; Ohno S
    Am J Ophthalmol; 1993 Oct; 116(4):406-9. PubMed ID: 8213969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Audio-vestibular disturbances in Behcet's patients: report of 62 cases.
    Kulahli I; Balci K; Koseoglu E; Yuce I; Cagli S; Senturk M
    Hear Res; 2005 May; 203(1-2):28-31. PubMed ID: 15855027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behçet's disease.
    Zouboulis CC; Turnbull JR; Martus P
    Adv Exp Med Biol; 2003; 528():123-6. PubMed ID: 12918675
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease.
    Mizuki N; Yabuki K; Ota M; Katsuyama Y; Ando H; Nomura E; Funakoshi K; Davatchi F; Chams H; Nikbin B; Ghaderi AA; Ohno S; Inoko H
    Tissue Antigens; 2002 Nov; 60(5):396-9. PubMed ID: 12492815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigen, severity and acetylator phenotype in Behçet's disease patients with non-relative parents.
    Sharquie KE; Najim RA; Al-Janabi MH
    Adv Exp Med Biol; 2003; 528():139-42. PubMed ID: 12918678
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Yoshida M; Onari K; Nikbin B; Davatchi F; Chams H; Ghaderi AA; Ohno S; Inoko H
    Tissue Antigens; 2001 May; 57(5):457-62. PubMed ID: 11556970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic comparison of Behçet's disease with or without HLA-Bw 51 antigen.
    Kim MS; Kim JH
    Korean J Ophthalmol; 1989 Dec; 3(2):85-9. PubMed ID: 2635747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA typing for class I and class H antigens in Iraqi patients with Behçet's disease (sporadic and familial cases).
    Al-Joofy IKh; Muslih RK; Mousawy KM; Al-Waiz MM
    Adv Exp Med Biol; 2003; 528():217-20. PubMed ID: 12918693
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary association of HLA-B51 with Behçet's disease in Ireland.
    Benezra D
    Br J Ophthalmol; 1998 Jun; 82(6):715. PubMed ID: 9797683
    [No Abstract]   [Full Text] [Related]  

  • 18. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome.
    Arber N; Klein T; Meiner Z; Pras E; Weinberger A
    Ann Rheum Dis; 1991 Jun; 50(6):351-3. PubMed ID: 2059078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of HLA with Behçet's disease and its significance].
    Si CW; Wong JH; Xi HL
    Zhonghua Nei Ke Za Zhi; 1988 Jun; 27(6):363-5, 390-1. PubMed ID: 3197510
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
    Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A
    Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.